Navigation Links
Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
Date:8/8/2008

ASHBURN, Va., Aug. 8 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the first of three ongoing phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the management of post-operative pain.

Innocoll's BUPIVACAINE SURGICAL IMPLANT is a biodegradable and fully bioresorbable matrix of purified fibrillar collagen impregnated with the local anesthetic, bupivacaine, which has been specifically developed and formulated using Innocoll's proprietary CollaRx sponge technology. It is under development in the US and Europe for the management of post-operative pain following moderate/major abdominal, gynecological, abdominal, thoracic, and orthopedic surgeries.

Post-operative pain is typically controlled with narcotic analgesics such as morphine, but systemic administration of these drugs can result in unfavorable side effects including suppression of breathing, sedation, nausea and vomiting, and can also affect patient recovery. Innocoll's BUPIVACAINE SURGICAL IMPLANT is intended to provide pain control directly at the surgical site and thus reduce the level of additional analgesia required following surgery. The collagen matrix naturally biodegrades over a few days and the bupivacaine is released to provide local analgesia for up to 96 hours post-operatively. A key feature of Innocoll's product is the ability to implant it directly into the surgical cavity and at different layers within the wound, such as across the peritoneal incision and directly below the skin incision, which enables localized treatment of both the incisional and deep, visceral pain components normally associated with moderate and major surgery. The bioresorbable nature of the collagen matrix also offers significant clinical benefits and convenience advantages over ambulatory infusion pumps which can be used to pro
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
3. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
6. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
7. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
10. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
11. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...9 Posit Science Corporation,resea...ty for Neuroscience,Annual Conference in Washingt...ng may benefit Baby Boomers. The computerized bra...es adaptive exercises that target auditory and,la...ve generalized,improvements in cognition by impro...
(Date:11/19/2008)... Isogen, a contract development an... today announced the first,phase launch of its co...,specifically address the process, facility and c...billion highly-niched, low-volume clinical and,ea...t. , Companies can invest over $100 million...
(Date:11/18/2008)...18 Forty-two leading U....ber national forum to consider cutting-edge innova...national economy from outbreaks of dangerous zoono... , Among those innovations: , , , ...en table that detects highly contagious and danger...
(Date:11/13/2008)...search Finds Statins Cut Risk of Heart Attacks, De.../ -- Cardiovascular Disease,is the leading cause o...stem hundreds of millions of dollars and causing u...ing this fatal disease - even among those who,were... that millions of people could cut their risk of a...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Isogen Launches Major New Facility to Address Global Biopharma Demand 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Seniors Can Be Heartened by New Study on Statins 2BioMarin Announces Program for ERT for Treatment of MPS IVA Morquio A Syndrome 5837 1BioMarin Announces Program for ERT for Treatment of MPS IVA Morquio A Syndrome 5837 2BioMarin Announces Program for ERT for Treatment of MPS IVA Morquio A Syndrome 5837 3BioMarin Announces Program for ERT for Treatment of MPS IVA Morquio A Syndrome 5837 4Ecological Society of America announces its 93rd Annual Meeting 3540 1Ecological Society of America announces its 93rd Annual Meeting 3540 2Ecological Society of America announces its 93rd Annual Meeting 3540 3A glass apart 21152 1Rush Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution 21148 1Rush Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution 21148 2Rush Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution 21148 3Rush Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution 21148 4
...tor The first human case of West Nile virus (WNV) ...n late June. The CDC has released few details on ...rst documented incidence of the mosquito borne dis...nded RNA flavivirus of about 11 kb. It primarily ... and other vertebrates serving as incidental hosts...
...cerides and cholesterols, vary with genetic predis...of these factors contribute to serum cholesterol a...isk of untoward vascular and cardiac events. Perha... values are so much in the public eye as serum lev...e discussion of plasma lipid test results an oppor...
Other Medicine Technology:West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 2West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 4Analyzers Offer Point-of-Care Lipid Panels 2Analyzers Offer Point-of-Care Lipid Panels 3
(Date:11/21/2008)...ng may lead to new therapies for preterm labor , ...earchers say they,ve found the switch that activat...dbirth, a finding that may lead to therapies for p...ally binds the protein IP on the surface of these ...tive during pregnancy. , But researchers from ...
(Date:11/21/2008)...al meeting of shareholders to be held on January 8...stCall/ - Med-Emerg International Inc. ("MedEmerg"... of health services, announced today that it has o... Court of Justice concerning its previously announ...nt to which AIM Health Group Inc. ("AIM") will acq...
(Date:11/21/2008)...TON(Nov. 21, 2008)The University of Texas Health S..., Training Excellence in Aging Studies (TEXAS), to...h a prestigious $2 million award from the Donald W...g funds., "This will allow us to teach geriatric ...or medical student to practicing physicians. With ...
(Date:11/21/2008)...AND, Colo., Nov. 21 Hesk...t will present at the New York Society of,Securit...ma Conference on,December 2, 2008 at 1177 Avenue ...resentation is scheduled to begin at 9:35 a.m. Eas...vailable via live webcast and for two weeks,follo...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4
...gular heart beats and have a tendency to form bloo...arts. These clots can then travel to the brain, bl...ng the risk of this occurring is to give drugs tha...ots. Two commonly used options are anticoagulants ...
...e chance of successfully quitting can be enhanced ... during their stay, and then have at least one mon... people, going in to hospital provides an opportun...als are now smoke-free, any smoker has to stop tem...
...a huge pink hot air balloon - is set Friday to fly...ness . The balloon - which organisers hope will en...d by seven local branches of the public medical se...al in Lichtenvoorde, a small town near Almelo in t...
...registration in certain parts of India is not sati...ar, 10 million still go unregistered . Two out of ...re do not exist for government planning purposes, ...rnmental organisation (NGO) said. The registratio...
Other Medicine News:Health News:Anticoagulants is Better for Atrial Fibrillation 2Health News:Hospital Provides an Oppurtunity to Quit Smoking 2Health News:Millions of Births Still Go Unreported in India 2
Medical Claims Billing
Managed care is a billing and tracking system.
Visionary OFFICE™ PM offers a Windows interface featuring medical billing, appointment scheduling and patient information.
HCS INTERACTANT is an integrated healthcare information system. Financial applications include general ledger, accounts payable, human resources and comprehensive management reporting. HCS general fi
Medicine Products: